Detection Is Not Prevention

We are getting better at finding things.

A smartwatch can flag an irregular rhythm. A blood panel can reveal a deteriorating marker before symptoms appear. Imaging can identify abnormalities that would once have remained invisible. Risk models can tell clinicians and patients where to look more carefully. This is real progress. Earlier detection can change treatment, prognosis, and sometimes survival.

There is also a terminology problem worth clearing up. In public-health language, early detection is commonly classified as secondary prevention. I am using prevention here in the more ordinary upstream sense: changing the conditions that make a harmful trajectory more likely before detection becomes the main event. The distinction matters because our ability to make risk visible is advancing faster than our ability to change the life in which that risk has to be managed.

---

A Warning Changes the Information, Not the Conditions

Imagine someone receives increasingly detailed information about their health. Sleep is poor. Blood pressure is rising. Glucose regulation is deteriorating. Activity is inconsistent. Recovery looks weak. None of that information is trivial. It may be exactly what finally gets someone’s attention.

Now look at the day receiving it. Work runs long. The commute is tiring. Family responsibilities begin when work ends. Exercise has to compete with whatever energy remains. Much of the social life that survives happens late in the day. The dashboard may be correct while the day remains almost exactly the same.

That is not a failure of detection. It is a reminder of what detection actually does. It changes what is known. Something else still has to change what becomes possible.

A large 2026 umbrella review of wrist-worn wearable interventions found a relatively consistent effect on physical activity, while effects across broader health outcomes were more mixed. More than 80 percent of the clinical trials in the underlying reviews combined wearable feedback with broader behavioral interventions. That distinction matters. The device supplied information and feedback. The intervention usually contained more than the device.

Earlier visibility can create an opportunity. It does not contain the implementation path.

---

Monitoring Is Moving Into Everyday Life

For most of medical history, diagnosis happened mainly when a person entered the medical system. Something hurt. A symptom persisted. A clinician examined the body, ordered a test, or interpreted a change. That boundary is becoming less clear.

Consumer wearables, home testing, continuous monitoring, risk scores, and increasingly predictive tools move parts of the diagnostic layer into ordinary life. The body can now produce signals while someone is walking to work, sleeping, eating lunch, or sitting in a meeting. A signal that would once have gone unnoticed may now become visible early enough to matter.

I know the appeal of this from the inside. Activity tracking had entered my own health practice years earlier, and by 2022 I had added a Garmin fēnix 7 to an increasingly detailed stream of personal data. I later described that period as the beginning of an “obsession” with measurement. The characterization is retrospective, but the escalation itself is easy to document. The data was useful. It also made something else visible: measuring more did not automatically tell me what every change meant or which ones deserved a response.

The mood around wearables and biohacking is beginning to change in a similar direction. The tools are not disappearing, and neither is the appetite for health data. But recent media requests have moved from what these devices can measure toward tracker obsession, people who tried optimizing everything with data and disliked the result, and even the “fall of biohacking.” Recent coverage has begun using the language of an “anti-optimization wave.” The emerging question is no longer simply whether more measurement is possible. It is whether more measurement is producing better judgment.

That question has begun to appear in research as well. A 2026 qualitative study of regular wearable users found recurring conflict around what happens when bodily experience and device data disagree, how much control the tracker acquires over behavior, and what users imagine would happen if they stopped tracking. The study was small, so it tells us about the shape of the conflict rather than how common it is. But the shape is recognizable.

As monitoring moves outward, it changes the distribution of work. The clinic no longer holds all the information. The person becomes a receiver, interpreter, and sometimes manager of a continuous stream of signals. A poor night becomes a sleep score. A meal can become a glucose curve. A difficult week becomes a change in HRV or recovery. A normal fluctuation can become something to investigate.

For some people, that feedback improves judgment. For others, it increases the amount of health information requiring judgment. More measurement can increase agency. It can also create more interpretation work.

---

The Next Step Is Not Contained in the Data

Health information is often described as actionable, as though the action were contained in the information itself. Usually it is not.

A sleep score can show that last night differed from baseline. It cannot tell someone whether the difference came from illness, alcohol, travel, training, a late conversation, sensor error, or ordinary variation. A glucose trace can make a response visible without deciding whether the important variable was the meal, its timing, what came before it, or a pattern that only becomes meaningful across several days. A recovery metric can change because of training, infection, emotional load, sleep, travel, or measurement noise.

The difficulty is not that the numbers are useless. It is that someone has to decide what is signal, what is noise, which change deserves attention, and when the evidence is strong enough to justify reorganizing behavior around it. More data can reduce one uncertainty while creating another: what deserves a response?

This is one reason a device can become authoritative without ever being diagnostic. Someone wakes feeling reasonably well, sees a poor readiness score, and begins interpreting the body through the score. Or the opposite happens: the number looks good while the person feels depleted. The disagreement creates a new decision problem. Which signal gets trusted?

For some people, the answer becomes more precise over time because the data is placed alongside experience rather than above it. For others, the stream of numbers becomes another source of vigilance. A tool intended to reduce uncertainty begins generating a queue of small interpretive tasks.

More information can increase agency. It can also increase the amount of judgment required to use that agency well.

---

A Signal Needs Somewhere to Go

The value of early detection depends partly on what can happen after the signal. WHO makes this explicit in formal screening: early detection has limited value when an abnormal finding cannot be followed by the diagnostic or treatment pathway needed to act on it. Consumer monitoring is not the same thing as a screening programme, but the boundary is useful. Detection creates an opportunity. The opportunity is not the response itself.

Outside the clinic, the same gap appears in less formal ways. Someone can receive useful information earlier and still lack the time, authority, money, clinical access, or support required to do something proportionate with it. A risk score may create time. Time is not the same thing as leverage.

This is where the word actionable becomes slippery. A recommendation may be medically sensible and still be difficult to use. But the important distinction is not simply between knowledge and motivation. It is between receiving a signal and having a credible next move.

Sometimes that move will be clinical. Sometimes it will be behavioral. Sometimes it will be to collect more information before acting at all. The signal itself cannot decide among those possibilities. It has to enter a context in which someone can interpret it, compare it with other evidence, and decide whether a response is warranted.

That is why earlier knowledge should not automatically create a harsher standard of self-surveillance. A person can know more and still need help deciding what the information means. They can understand a risk and still face constraints on what they can change. They can be attentive without treating every deviation as a problem to solve.

Detection deserves its own value. It can surface a problem earlier, improve clinical decisions, and create time that did not exist before. The mistake is asking visibility to count as trajectory change.

---

After any warning, the useful question is not only, “What did we find?” It is also, “What can knowing this now make possible?” If the answer is nothing different, the measurement may still be informative. It has not yet become prevention in the upstream sense I mean here.See how the Human OS fits together →If this helped you name something you have been feeling but had not quite put into words, please share it with someone who might need the same language.Share

---

The Human OS Manual is now . If this work resonates, you can reserve your copy and follow the ideas here as they continue to develop.

Feel free to leave a comment. I read and respond to every thoughtful note.

---

Notes and Sources

• World Health Organization, “Health promotion and disease prevention through population-based interventions, including action to address social determinants and health inequity,” including definitions of primary and secondary prevention and the limits of early detection when follow-up services are unavailable.
• Marija Glisic et al., “An Umbrella Review of Systematic Reviews of the Impact of Wrist-Worn Wearables on Health Outcomes,” Physiological Reviews (2026).
• Gabrielle Humphreys, Sam Jensen, and Ashley Gluchowski, “It’s like a toxic relationship: Examining internal conflict experienced in wearable activity tracker users,” PLOS Digital Health (2026).
• Rachael Akhidenor, “Meet the Wellness Brands Riding the Anti-Optimization Wave,” Vogue (2026).